According to Gram Research analysis, high-dose vitamin D3 supplementation significantly reduces blood vessel damage and prevents kidney injury in an animal model of obstructive sleep apnea combined with vitamin D deficiency. In a 14-day study of 56 rats, high-dose vitamin D (37.5 micrograms per kilogram daily) normalized blood vessel damage markers and completely prevented kidney tubule injury, while low-dose vitamin D showed only partial protection. These findings suggest vitamin D supplementation could help protect the heart and kidneys in sleep apnea patients, though human trials are needed to confirm effectiveness and safe dosing.
A new study found that vitamin D deficiency makes sleep apnea worse by damaging blood vessels and kidneys. Researchers gave rats with sleep apnea different doses of vitamin D3 and found that higher doses significantly reduced blood vessel damage and kidney injury. The study suggests that vitamin D supplementation could be a helpful treatment to prevent heart and kidney problems in people with obstructive sleep apnea, a common condition where breathing stops repeatedly during sleep.
Key Statistics
A 2026 animal study of 56 rats found that high-dose vitamin D3 supplementation reduced PCSK9 (a blood vessel damage marker) from 213.50 nanograms per milliliter in untreated sleep apnea rats to 162.50 nanograms per milliliter, nearly normalizing levels.
Rats with combined vitamin D deficiency and sleep apnea-like conditions developed kidney tubule damage, but this damage was completely prevented in all groups receiving vitamin D supplements, regardless of dose, according to a 2026 animal study.
In a 2026 study of 56 rats, high-dose vitamin D3 supplementation increased nitric oxide levels from 14.88 micromoles per liter (in untreated sleep apnea rats) toward normal control levels, improving blood vessel function.
A 2026 animal study found that rats with both vitamin D deficiency and sleep apnea showed peak E-selectin levels of 4.92 nanograms per milliliter, indicating severe blood vessel activation, which was substantially reduced by high-dose vitamin D supplementation.
The Quick Take
- What they studied: Whether vitamin D supplements could reduce blood vessel damage and kidney injury caused by obstructive sleep apnea combined with vitamin D deficiency.
- Who participated: 56 adult male rats divided into seven groups, some with vitamin D deficiency and sleep apnea-like conditions, others receiving different doses of vitamin D3 supplements for 14 days.
- Key finding: High-dose vitamin D3 (37.5 micrograms per kilogram daily) significantly reduced markers of blood vessel damage and completely prevented kidney injury in rats with both sleep apnea and vitamin D deficiency, while low-dose vitamin D showed only partial improvement.
- What it means for you: If these findings translate to humans, vitamin D supplementation might help protect the heart and kidneys in people with sleep apnea, especially those who are vitamin D deficient. However, this was an animal study, so human trials are needed before making treatment recommendations.
The Research Details
Researchers used 56 adult male rats to test whether vitamin D supplements could protect blood vessels and kidneys damaged by sleep apnea. They created seven groups: a healthy control group, a vitamin D-deficient group, and five groups with vitamin D deficiency combined with sleep apnea-like conditions (created by exposing rats to low oxygen levels). Some groups received high-dose vitamin D (37.5 micrograms per kilogram daily), others received low-dose vitamin D (25 micrograms per kilogram daily), and some received no supplement. The study lasted 14 days.
Researchers measured several markers of blood vessel damage in the rats’ blood, including proteins that indicate inflammation and stress on blood vessel walls. They also examined kidney tissue under a microscope to look for damage. All measurements were compared between groups using statistical tests to determine if differences were real and significant.
The study was designed to test whether vitamin D dose matters for protecting blood vessels and kidneys in sleep apnea. This is important because sleep apnea causes repeated drops in oxygen levels, which damages blood vessels through oxidative stress, a type of cellular damage. Vitamin D deficiency, which is common in sleep apnea patients, may make this damage worse.
This research approach matters because it tests a specific mechanism: whether vitamin D can counteract the blood vessel and kidney damage caused by sleep apnea. By using a controlled animal model, researchers could precisely measure damage and test different doses to find the most effective treatment. This type of foundational research helps identify promising treatments before testing them in humans.
This study has several strengths: it used a large sample size for animal research (56 rats), tested multiple doses to understand dose-response relationships, measured multiple markers of blood vessel damage rather than just one, and included microscopic examination of kidney tissue by a researcher who didn’t know which group each sample came from (blinded assessment). However, as an animal study in rats, results may not directly apply to humans. The study was relatively short (14 days), so long-term effects are unknown. Additionally, the study only included male rats, so results may differ in females.
What the Results Show
Rats with both vitamin D deficiency and sleep apnea-like conditions showed the most severe blood vessel damage. Their blood contained very high levels of proteins indicating blood vessel stress: E-selectin at 4.92 nanograms per milliliter, ICAM-1 at 201.50 nanograms per milliliter, and ET-1 at 5.31 picograms per milliliter. These levels were significantly higher than healthy control rats. The same group also had the lowest levels of nitric oxide (14.88 micromoles per liter), a molecule that helps blood vessels relax and function properly.
When researchers gave high-dose vitamin D3 supplements, blood vessel damage markers improved dramatically across all measurements. PCSK9, a protein linked to cholesterol problems and blood vessel damage, dropped from 213.50 nanograms per milliliter in untreated rats to 162.50 nanograms per milliliter in high-dose supplemented rats, nearly returning to normal control levels. Low-dose vitamin D showed improvement but didn’t fully normalize these markers.
Kidney damage was particularly striking. Rats with vitamin D deficiency and sleep apnea developed kidney tubule damage (vacuolisation in the proximal tubules), which is a sign of cellular injury. This damage was completely absent in all groups that received vitamin D supplements, regardless of dose. Kidney tissue from supplemented rats looked nearly identical to healthy control rats.
The study found that the severity of sleep apnea conditions (moderate versus severe oxygen deprivation) affected how well vitamin D worked. High-dose vitamin D was more effective under severe conditions than low-dose vitamin D. The glomeruli, the filtering units of the kidney, remained structurally normal in all groups, suggesting that vitamin D protected the kidney’s filtering function. Some groups showed mild inflammation in kidney tissue (lymphocytic infiltration), but this was not prevented by vitamin D supplementation, indicating that vitamin D’s protective effect was specific to tubular damage rather than general inflammation.
This research builds on previous findings showing that vitamin D deficiency worsens cardiovascular complications in sleep apnea patients. Earlier studies demonstrated that sleep apnea causes blood vessel dysfunction through oxidative stress and reduced nitric oxide production. This study is the first to systematically test whether vitamin D supplementation can reverse this damage in a combined model of both vitamin D deficiency and sleep apnea. The dose-dependent response (higher doses working better) aligns with other vitamin D research showing that therapeutic effects often require adequate dosing.
This study has important limitations. It was conducted in rats, not humans, so results may not directly translate to people with sleep apnea. The study lasted only 14 days, which is too short to assess long-term safety or effectiveness. Only male rats were studied, so results may differ in females or in people of different sexes. The study didn’t test whether vitamin D supplementation would work in people who already have established blood vessel or kidney damage, only in preventing damage. Additionally, the study didn’t measure whether vitamin D improved actual sleep apnea severity or oxygen levels, only markers of blood vessel and kidney damage.
The Bottom Line
Based on this animal research, vitamin D supplementation appears promising for protecting blood vessels and kidneys in sleep apnea, particularly at higher doses. However, this is preliminary evidence from rats. People with sleep apnea should discuss vitamin D testing and supplementation with their doctor, especially if they have low vitamin D levels. The standard recommendation for vitamin D supplementation in adults is 600 to 800 IU daily, though some people need higher doses. This study suggests higher doses may be more protective, but human trials are needed to confirm safe and effective dosing. Confidence level: Low to moderate, as this is animal research requiring human confirmation.
People with obstructive sleep apnea, particularly those with vitamin D deficiency, should be interested in this research. People with heart disease or kidney disease related to sleep apnea may especially benefit if these findings translate to humans. People without sleep apnea or with normal vitamin D levels may not see the same protective benefits. Pregnant women, children, and people with certain kidney diseases should consult their doctor before increasing vitamin D supplementation.
In this animal study, protective effects appeared within 14 days. In humans, vitamin D effects typically take 4 to 8 weeks to become apparent, as vitamin D accumulates in the body over time. Kidney and heart protection would likely take longer to measure, potentially several months to a year of consistent supplementation.
Frequently Asked Questions
Can vitamin D supplements help with obstructive sleep apnea?
A 2026 animal study suggests high-dose vitamin D3 may protect blood vessels and kidneys damaged by sleep apnea. However, this was rat research, so human trials are needed. People with sleep apnea should discuss vitamin D testing and supplementation with their doctor.
What dose of vitamin D is needed to protect against sleep apnea damage?
The animal study tested high-dose (37.5 micrograms per kilogram daily) and low-dose (25 micrograms per kilogram daily) vitamin D, with high-dose showing better results. Standard human recommendations are 600 to 800 IU daily, but optimal doses for sleep apnea protection remain unknown and require human research.
Does vitamin D deficiency make sleep apnea worse?
A 2026 animal study found that vitamin D deficiency combined with sleep apnea caused severe blood vessel damage and kidney injury. Rats with both conditions showed significantly higher blood vessel damage markers than those with sleep apnea alone, suggesting vitamin D deficiency amplifies sleep apnea complications.
How long does it take for vitamin D to protect the heart and kidneys?
In the animal study, protective effects appeared within 14 days. In humans, vitamin D effects typically take 4 to 8 weeks to accumulate. Heart and kidney protection would likely require several months of consistent supplementation, though this hasn’t been tested in people yet.
Should everyone with sleep apnea take vitamin D supplements?
This animal study suggests vitamin D may help, but human evidence is lacking. People with sleep apnea should have their vitamin D levels tested and discuss supplementation with their doctor. Standard treatment for sleep apnea (CPAP machines) remains the primary recommendation.
Want to Apply This Research?
- Track daily vitamin D supplementation dose and timing, along with weekly blood oxygen saturation readings (if available from a wearable device) and monthly energy levels or daytime sleepiness scores using a simple 1-10 scale.
- Set a daily reminder to take vitamin D supplements at the same time each day, ideally with a meal containing fat for better absorption. Log the dose taken and note any changes in sleep quality or daytime alertness over 8 to 12 weeks.
- Establish a baseline vitamin D level through blood testing before starting supplementation, then retest after 8 to 12 weeks. Track sleep apnea symptoms (snoring, witnessed apneas, daytime sleepiness) monthly. Consider periodic blood pressure monitoring, as blood vessel function improvements may affect blood pressure.
This article describes animal research findings and should not be interpreted as medical advice for humans. Obstructive sleep apnea is a serious medical condition requiring professional diagnosis and treatment. While this study suggests vitamin D supplementation may have protective effects, human clinical trials are needed before recommending vitamin D as a treatment for sleep apnea complications. People with sleep apnea should continue using prescribed treatments (such as CPAP machines) and consult their healthcare provider before starting any new supplements. Vitamin D supplementation may interact with certain medications or be inappropriate for people with specific health conditions. Do not self-treat based on this research.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.